- Delivra Health Brands (TSXV:DHB) plans to launch a new line of kids sleep gummies under its Dream Water brand across the US market this June
- The alternative wellness solutions company is on a mission to help customers reclaim their energy, mobility and overall quality of life
- Delivra Health stock last traded at C$0.14 and has given back 33.33 per cent year-over-year
Delivra Health Brands (TSXV:DHB) plans to launch a new line of kids sleep gummies under its Dream Water brand across the US market this June.
Each gummy includes chamomile, lemon balm and 1 mg of melatonin, a hormone that helps regulate your sleep cycle, and is lightly sweetened with honey and cane sugar, while containing no gelatin, gluten or artificial colors or flavors.
Dream Water Kids Sleep Gummies will be made available to e-commerce and brick-and-mortar channels, with leadership keen to build upon an attractive financial track record over the past five years, as detailed in the company’s latest investor deck, marked by revenue growth from C$7.7 million in 2020 to C$13.3 million in 2025, gross profit growth from 9 per cent to 51 per cent, respectively, as well as positive adjusted EBITDA since 2023.
Gord Davey, president and chief executive officer of Delivra Health, added context to the upcoming sleep gummies launch in Friday’s news release, noting that it represents “another meaningful step forward in our ongoing commitment to innovation and delivering relevant, high-quality products that truly meet consumers’ wellness needs.”
“Our Dream Water Kids Sleep Gummies address the needs of families seeking sleep solutions by providing parents with a trusted, convenient option to support their children’s sleep routines,” he added. “Following multiple successful testing phases, the positive feedback we received caused us to accelerate our planned launch to June 2026.”
Delivra’s business fundamentals have continued to show strength in Q1 and Q2 of fiscal 2026, with several new product launches expected to foster growth through the year.
About Delivra Health Brands
Delivra Health Brands offers alternative wellness solutions designed to help customers reclaim their energy, mobility and overall quality of life. The company’s brand portfolio includes Dream Water and LivRelief.
Delivra Health stock (TSXV:DHB) last traded at C$0.14 and has given back 33.33 per cent year-over-year.
Join the discussion: Find out what investors are saying about this small-cap healthcare stock on the Delivra Health Brands Inc. Bullboard and make sure to explore the rest of Stockhouse’s stock forums and message boards.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein.
For full disclaimer information, please click here.
